CME Group Inc.
CME | NASDAQ
$302.33
-$0.81 (-0.27%)
Nov 2, 2026, 10:35 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 6.52B | 6.13B | 5.58B | 5.02B | 4.69B | 4.88B |
Cost of Revenue | 907M | 850.3M | 828.6M | 753.1M | 837M | 856.5M |
Gross Profit | 5.61B | 5.28B | 4.75B | 4.27B | 3.85B | 4.03B |
Operating Income | 4.23B | 3.93B | 3.44B | 3.02B | 2.65B | 2.64B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 5.33B | 4.54B | 4.15B | 3.49B | 3.37B | 2.72B |
Net Income | 4.04B | 3.53B | 3.23B | 2.69B | 2.64B | 2.11B |
Selling & General & Admin | 150.5M | 132.7M | 144.4M | 137.4M | 151.7M | 191.3M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 1.23B | 1.22B | 1.17B | 1.11B | 1.06B | 1.2B |
Operating Expenses | 1.38B | 1.35B | 1.31B | 1.25B | 1.21B | 1.39B |
Interest Expense | 129.7M | 160.9M | 159.4M | 162.7M | 166.9M | 166.2M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.29B | 2.2B | 2.14B | 2B | 2.04B | 2.25B |
Income Tax Expense | 1.27B | 1.02B | 927.4M | 799.3M | 736.7M | 615.7M |
Shares Outstanding (Basic) | 359.63M | 359.39M | 359.02M | 358.71M | 358.34M | 357.76M |
Shares Outstanding (Diluted) | 360.23M | 359.94M | 359.5M | 359.18M | 358.93M | 358.52M |
EPS (Basic) | 11.18 | 9.69 | 8.87 | 7.41 | 7.30 | 5.88 |
EPS (Diluted) | 11.16 | 9.67 | 8.86 | 7.40 | 7.29 | 5.87 |
EBITDA | 5.78B | 5.04B | 4.67B | 4.02B | 3.93B | 3.35B |
EBIT | 5.45B | 4.7B | 4.31B | 3.65B | 3.54B | 2.89B |
Depreciation & Amortization | 330.9M | 336.8M | 352.6M | 362.6M | 385.4M | 464.4M |
Add to Watchlist
Select watchlists to add or remove CME